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Purpose: To identify mutations within the TGFBI gene in a Chinese family with lattice corneal dystrophy type I (LCD
I).
Methods: Genomic DNA of three affected, four unaffected family members and 50 normal individuals was extracted
from peripheral leukocytes. All exons of TGFBI were amplified by polymerase chain reaction (PCR) methods and direct
sequencing was carried out for mutation analysis.
Results: A missense mutation (1565T→A) in exon12 of TGFBI led to an amino acid substitution I522N in the TGFB-
induced protein in all affected family members, but the mutation was not detected in normal subjects of the family and
control individuals.
Conclusions: We conclude that the novel mutation I522N causes lattice corneal dystrophy type I in the studied family.
This is the first report of the I522N mutation within TGFBI in LCD I worldwide.
Corneal dystrophies are hereditary diseases characterized
by corneal opacities on different layers of the cornea. Lattice
corneal  dystrophy  is  known  as  an  autosomal  dominant
disease.  Histological  examination  of  corneal  specimens
shows amyloid deposits. The typical clinical appearance of
LCD  I  (LCD  I;  OMIM  122200)  is  characterized  by
subepithelial and stromal branching lattice lines. Generally,
the clinical symptoms become evident in the patient’s first or
second decade, with the appearance of white-grayish opacities
in the superficial stromal layer of the cornea. Thereafter, the
lesions tend to become larger, aggregate, and extend deeper
and toward the periphery over time.
The  transforming  growth  factor-beta-induced  gene
(TGFBI)  is  located  on  the  human  chromosome  5q31  [1].
Munier et al. [1] reported that mutations in TGFBI caused
lattice  corneal  dystrophy  type  Ι.  To  date,  the  mutations
reported in TGFBI as the causation of LCD type Ι include
R124C, V505D, L518P, V539D, A546D, P551Q, L569R,
H572R,  and  V625D  [2-4].  The  following  mutations  in
TGFBI  causing  LCDI  have  been  identified  in  Chinese
families: R124C, V625D, and V505D [5,6]. In this study, we
described a novel mutation I522N in TGFBI inducing LCDI
in  a  Chinese  family.  None  of  the  previously  reported
mutations in the TGFBI gene were found in this family.
METHODS
Patients: This study was approved by the Institutional Review
Board of Harbin Medical University (Harbin, China). Four
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affected and six unaffected individuals from a Chinese family
(Figure1) were enrolled in this study after obtaining informed
consent. Fifty unrelated healthy individuals were selected as
the control group and they were all Chinese. All subjects,
including  control  individuals,  underwent  clinical
ophthalmologic examination and slit lamp photographs of
affected eyes were taken.
Molecular genetic analysis: Peripheral blood (5 ml) was taken
from patients, unaffected family members, and 50 healthy
controls.  Genomic  DNA  was  extracted  from  peripheral
leukocytes, according to the manufacturer's (Tiangen Biltech
Co. Ltd, Beijing, China) standard methods. All 17 exons of
TGFBI were amplified by polymerase chain reaction (PCR)
using  the  primers  described  previously  [7].  PCRs  were
Figure  1.  Pedigree  analysis  and  pedigree  symbols.  The  squares
indicate males and the circles indicate females. A filled symbol
indicates a person affected with LCD I. The arrow indicates the
proband.
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2498performed in a 50 μl volume containing 10× PCR buffer, 10–
200 ng of genomic DNA, 0.2 mM of each dNTP, 1 unit of Taq
polymerase, and 1 μl of 1 mM forward and reverse primers.
The primer annealing temperature was adjusted separately for
each PCR reaction, which was based on those described by Li
et al. [7]. After pre-denaturation at 95 °C for 5 min, DNA
fragments  were  amplified  for  35  cycles  of  denaturation,
annealing, and extension, followed by a final extension step
at 72 °C for 10 min. PCR products were analyzed in 2%
agarose  gel,  from  which  the  bands  with  the  amplified
templates were examined and subsequently purified with a
TIANgel Midi Purification Kit (Tiangen Biltech Co. Ltd) and
sequenced with an ABI BigDye Terminator Cycle Sequencing
kit  v3.1  (ABI  Applied  Biosystems,  Foster  City,  CA).
Nucleotide  sequences  of  PCR  products  were  manually
compared  with  NCBI  TGFBI  Gene  Reference  Sequences
(NM_000358.2).
RESULTS
Clinical findings: The common feature of corneal lesion in the
pedigree  was  that  the  onset  of  the  disease  occurred  in
adulthood, approximately in the second decade of life, and is
characterized by ocular pain, photophobia, and progressive
visual defect. Clinical data of patients from the family were
shown  in  Table1.  Slit  lamp  examination  revealed  typical
symmetric  branching  lattice  lines  in  the  central  anterior
stroma of the proband. The proband's mother showed new
corneal vessels with recurrent corneal erosion and multiple
Figure 2. Clinical photographs of affected family members with LCD I. A and B: Slit lamp appearance of a cornea of a proband at 16 years
of age shows distinct refractile lattice lines and diffuse opacification in the subepithelial and anterior stromal layer in the left eye. C: The
photograph demonstrates central anterior stromal clouding in the proband’s right eye. D: The photograph shows lattice opacities with the
appearance of new vessels in the subepithelial and anterior stromal cornea of the proband’s mother, with recurrent disease in the right eye.
E: The image of the proband’s mother reveals thick linear opacities and diffuse grayish-white clouding, which partly covers the original lattice
lines within the central area of the cornea in the left eye.
TABLE 1. CLINICAL DATA FOR THE AFFECTED MEMBERS IN THE FAMILY WITH THE TGFBI I522N MUTATION.
 Visual acuity at  t presentation
Individual case Age Age at onset OD OS
III-1 16 12 0.3 0.4
II-6 38 13 0.06 0.12
II-1 46 15 HM/50 cm HM/30 cm
II-2 43 13 0.1 HM/50 cm
The Snellen visual acuity scale was used in these studies. In the table, HM indicates hand movement.
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2499thick subepithelial, stromal lattice opacification (Figure2). All
of  the  affected  individuals  were  referred  to  appropriate
specialists for a work-up for systemic amyloidosis. However,
no features of this discovery were detected.
Gene  analysis:  Exon  12  of  TGFBI  of  the  affected  and
unaffected  individuals  was  analyzed  by  direct  sequencing
Figure 3. Partial nucleotide sequence of exon 12 of TGFBI in affected
and unaffected individuals. A: A normal sequence is shown where
the isoleucine is encoded by codon 522. B and C: The forward and
reverse sequence shows a heterozygous genotype (1565T→A) in all
the  affected  family  members,  which  resulted  from  a  change  of
isoleucine (ATC) to asparagine (AAC) at codon 522, thus altering
the structure and property of the protein.
(Figure3).  The  sequence  of  the  patients  revealed  a
heterozygous  T→A  mutation  at  nucleotide  1565.  This
nucleotide substitution resulted in an amino acid replacement
from isoleucine (ATC) to asparagine (AAC) at codon 522
(I522N).  The  reverse  sequence  of  the  mutation  showed  a
corresponding  base  replacement  A>T,  which  further
confirmed the mutation. No other non-pathogenic SNPs were
observed in the other remaining TGFBI exons of the family.
The homologous sequences within the TGFBI protein from
diverse species were listed in Figure4. The alignment shows
that the mutation I522N is located at a highly conserved site.
DISCUSSION
In 1992, TGFBI (BIGH3) was first isolated by Skonier et al.
[8] in a study of genes induced by the transforming growth
factor-ß (TGFß) in a human adenocarcinoma cell line derived
from the lung. TGFBI (BIGH3) was found to be expressed in
the corneal epithelium [9]. So far, all the pathogenic mutations
reported on TGFBI are only related to corneal dystrophies,
which  are  characterized  by  progressive  accumulation  of
deposits in the cornea [10]. It has been shown that corneal
deposits are made of the mutant KE protein [11]. The genetic
studies  revealed  specific  missense  mutations  in  TGFBI,
causing  diverse  hereditary  corneal  dystrophies.  The  most
frequent types of these dystrophies result from mutations at
two hot spots, which are localized at codons Arg124 and
Arg555 [12].
The TGFBI gene product is a secreted protein of 683
amino acids, consisting of four regions of internal homology
of approximately 140 amino acids and a carboxy terminal
Arg-Gly-Asp (RGD) sequence. The tandem repeated regions
are  known  as  FAS1  domains.  These  four  FAS1  domains
correspond  to  amino  acids  134-236  (FAS1-1),  242-372
(FAS1-2), 373-501 (FAS1-3), and 502-632 (FAS1-4) [13].
All the mutations of TGFBI that cause corneal dystrophy are
located in FAS1 domain 4, with the exception of Arg124
[13]. Clout et al. [14] made a homology model of the FAS1
domain 4 of TGFBI protein, which suggested the common
mutations of TGFBI at positions 124 and 555 are likely to
affect protein-protein interactions directly, whereas the rare
mutations are likely to cause misfolding of the protein within
the cell.
The mutation described in this study is located in residue
522 and in the fourth FAS1 as well. This residue is conserved
among several species and thought of as a distinct functional
and/or structural sequence of the protein induced by TGFB
gene. According to the model of Clout et al. [14], Ile522 is a
hydrophobic residue and situated in helix α1. The mutation
alters highly conserved residue and leads to the substitution
of  hydrophilic  residue  for  hydrophobic  residue.  The
nucleotide  replacement  may  alter  the  protein's  physico-
chemical property and affect proper folding of the protein
within the cell, which results in abnormal corneal deposits and
corneal dystrophy.
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2500To  date,  five  types  of  LCD  have  been  established
according  to  the  stromal  location  of  deposits,  the
characteristics of lattice lines, and the age of onset. The five
types are I, II, III, IIIA, and IV [15]. Only LCD type II is
caused by mutations in the GSN gene, while the others are all
linked to mutant TGFBI and different phenotypes resulting
from distinct mutation points in the same gene. In addition,
several atypical forms of LCD, which can not be classified as
LCD  I,  II,  III,  IIIA,  and  IV,  have  been  observed  to  be
associated with various TGFBI mutations [16-18]. Genetic
testing of TGFBI mutations in LCD patients will contribute to
the clinical classification, correct diagnosis, prevention and
treatment level of hereditary disease. For those individuals,
genetic testing at an early age may improve clinical outcomes
by encouraging frequent ocular examination and thus laying
a solid foundation for genetic therapy.
This is the fourth genetic mutation reported in association
with the classic type I of LCD. The novel gene mutation
expands the mutation spectrum of TGFBI and contributes to
the study of molecular pathogenesis of corneal dystrophy.
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